Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0388220080150030197
Journal of the Korean Rheumatism Association
2008 Volume.15 No. 3 p.197 ~ p.203
Glucosamine Sulfate and Chondroitin Sulfate for the Treatment of Osteoarthritis
Lee Young-Ho

Ji Jong-Dae
Song Gwan-Gyu
Abstract
Osteoarthritis (OA) is the most common form of arthritis often associated with morbidity, disability, functional impairment and impaired quality of life. A new perspective in OA management is to delay disease progression by modifying joint structure. Glucosamine sulfate (GS) and chondroitin sulfate (CS) have attracted a lot of interest as a specific drug for OA. Glucosamine is a constituent of glcosaminoglycans in cartilage matrix and synovial fluid and is involved in cartilage formation. Chondroitin sulfate (CS) belongs to the glycosaminoglycan group and is a major component of the articular cartilage. The meta-analyses have shown that GS (but not glucosamine hydrochloride) and CS have small-to-moderate symptomatic efficacy in OA. With respect to the structure-modifying effect, there is some evidence that GS and CS may interfere with structural progression of OA.
KEYWORD
Glucosamine, Chondroitin, Osteoarthritis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø